0001209191-23-033841.txt : 20230602
0001209191-23-033841.hdr.sgml : 20230602
20230602164638
ACCESSION NUMBER: 0001209191-23-033841
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230601
FILED AS OF DATE: 20230602
DATE AS OF CHANGE: 20230602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kunz Barbara Lopez
CENTRAL INDEX KEY: 0001679970
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 23989667
MAIL ADDRESS:
STREET 1: 2401 4TH AVENUE
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-01
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001679970
Kunz Barbara Lopez
C/O APTEVO THERAPEUTICS INC.
2401 4TH AVENUE, SUITE 1050
SEATTLE
WA
98121
1
0
0
0
0
Common Stock
2023-06-01
4
M
0
297
A
1309
D
Restricted Stock Unit
2023-06-01
4
M
0
297
0.00
D
Common Stock
297
298
D
Restricted Stock Unit
2023-06-02
4
A
0
3571
0.00
A
Common Stock
3571
3571
D
Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.
The RSUs vest in full on the first anniversary of the date of grant.
/s/ SoYoung Kwon, Attorney-in-Fact
2023-06-02